Ligan, Ronald N.

HRN: 26-78-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
CEFTRIAXONE 1G (VIAL)
03/08/2025
03/15/2025
IV
1g
Q12
Lacerated Wound Frontal Area Right, Lacerated Wound Frontal To Nasal Bridge Area, Avulsed Wound Left Nostril
Waiting Final Action 
03/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/08/2025
03/15/2025
IV
600mg
Q8
Lacerated Wound Frontal Area Right, Lacerated Wound Frontal Area To Nasal Bridge, Avulsed Wound Left Nostril
Waiting Final Action 
03/08/2025
CEFTRIAXONE 1G (VIAL)
03/08/2025
03/15/2025
IV
2gm
OD
Multiple Lacerated Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: